Description
MOZOBIL (plerixafor) injection is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma
| Strength | 20 mg/ml |
| Pack Size | Not specified |
| Brand | Celrixafor |
| Packaging Type | Not specified |
| Composition | Not specified |
| Form | Injection |
| Shelf Life | Not specified |
| Usages | Not specified |
| Country of Origin | Made in India |
